33,232 followers
New Research: Cost-effectiveness of serplulimab as first-line therapy for extensive-stage small cell lung cancer in China: Objective The ASTRUM-005 trial demonstrated that adding serplulimab to chemotherapy significantly prolonged the… #immunology https:/